- Home
- ORGO vs ORC Comparison
ORGO vs ORC Comparison
Compare ORGO & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- ORC
- Stock Information
- Founded
- ORGO 1985
- ORC 2010
- Country
- ORGO United States
- ORC United States
- Employees
- ORGO N/A
- ORC N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- ORC Real Estate Investment Trusts
- Sector
- ORGO Health Care
- ORC Real Estate
- Exchange
- ORGO Nasdaq
- ORC Nasdaq
- Market Cap
- ORGO 665.8M
- ORC 623.6M
- IPO Year
- ORGO N/A
- ORC 2013
- Fundamental
- Price
- ORGO $4.28
- ORC $7.47
- Analyst Decision
- ORGO Buy
- ORC Buy
- Analyst Count
- ORGO 2
- ORC 3
- Target Price
- ORGO $5.50
- ORC $9.50
- AVG Volume (30 Days)
- ORGO 1.3M
- ORC 3.1M
- Earning Date
- ORGO 05-08-2025
- ORC 04-24-2025
- Dividend Yield
- ORGO N/A
- ORC 19.30%
- EPS Growth
- ORGO N/A
- ORC N/A
- EPS
- ORGO N/A
- ORC 0.58
- Revenue
- ORGO $482,043,000.00
- ORC $54,406,000.00
- Revenue This Year
- ORGO N/A
- ORC N/A
- Revenue Next Year
- ORGO $7.62
- ORC $51.24
- P/E Ratio
- ORGO N/A
- ORC $12.96
- Revenue Growth
- ORGO 11.29
- ORC N/A
- 52 Week Low
- ORGO $2.17
- ORC $7.36
- 52 Week High
- ORGO $6.71
- ORC $9.01
- Technical
- Relative Strength Index (RSI)
- ORGO 43.72
- ORC 22.99
- Support Level
- ORGO $4.80
- ORC $7.36
- Resistance Level
- ORGO $5.57
- ORC $8.29
- Average True Range (ATR)
- ORGO 0.32
- ORC 0.17
- MACD
- ORGO -0.15
- ORC -0.09
- Stochastic Oscillator
- ORGO 3.73
- ORC 10.19
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc invests in residential mortgage-backed securities (RMBS) across the United States. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.